nitroglycerin has been researched along with inosine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Meisel, M; Meisel, P | 1 |
| Canver, CC; Chopra, PS; Cook, TD; Hegge, JO; Lasley, RD; Love, RB; Mentzer, RM; Molina-Viamonte, V; Rahko, PS | 1 |
1 review(s) available for nitroglycerin and inosine
| Article | Year |
|---|---|
[Is adenosine the mediator for the regulation of the coronary circulation and for the effect of coronarodilators? Review].
Topics: Adenosine; Adenosine Triphosphate; Aminohydrolases; Aminophylline; Animals; Calcium; Carbon Dioxide; Coronary Circulation; Coronary Vessels; Dipyridamole; Dogs; Hydrogen-Ion Concentration; Hypoxanthines; Hypoxia; Inosine; Nitroglycerin; Oxidative Phosphorylation; Oxygen Consumption; Papaverine; Partial Pressure; Prenylamine; Theophylline; Vasodilator Agents; Verapamil | 1974 |
1 trial(s) available for nitroglycerin and inosine
| Article | Year |
|---|---|
Safety, tolerance, and efficacy of adenosine as an additive to blood cardioplegia in humans during coronary artery bypass surgery.
Topics: Adenosine; Adolescent; Cardioplegic Solutions; Cardiovascular Agents; Coronary Artery Bypass; Dopamine; Drug Tolerance; Echocardiography; Female; Heart; Humans; Hypoxanthine; Inosine; Male; Myocardial Stunning; Nitroglycerin; Safety; Vasodilator Agents | 1997 |
1 other study(ies) available for nitroglycerin and inosine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |